These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31055550)

  • 1. Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism.
    Feysa SV; Chopei IV
    Wiad Lek; 2019; 72(4):650-653. PubMed ID: 31055550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders.
    Feisa SV; Chopei IV
    Wiad Lek; 2018; 71(2 pt 1):261-264. PubMed ID: 29729151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
    Zhaldak DA; Melekhovets OK; Orlovskyi VF
    Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions.
    Li H; Hu B; Wei L; Zhou L; Zhang L; Lin Y; Qin B; Dai Y; Lu Z
    Eur J Neurol; 2018 Mar; 25(3):577-e34. PubMed ID: 29281159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To Assess Non Alcoholic Fatty Liver Disease in Patients with Clinical and Subclinical Hypothyroidism.
    R M; R M; S R; Ganga R
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity].
    Komshilova KA; Troshina EA; Ershova EV; Mazurina NV; Platonova NM
    Ter Arkh; 2014; 86(10):27-32. PubMed ID: 25509888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prospects for the application of the natural and preformed therapeutic factors in the treatment of non-alcoholic fatty liver disease].
    Zabolotnaya IB
    Vopr Kurortol Fizioter Lech Fiz Kult; 2016; 93(4):42-48. PubMed ID: 27500678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany.
    Labenz C; Kostev K; Armandi A; Galle PR; Schattenberg JM
    United European Gastroenterol J; 2021 Sep; 9(7):829-836. PubMed ID: 34288580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FEASIBILITY OF CYSTATIN C DETERMINATION FOR EARLY DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH TYPE 2 DIABETES COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY EXPOSED TO COVID-19 INFECTION IN THE PAST.
    Sabovchyk KV; Sirchak YS; Stryzhak VV
    Wiad Lek; 2021; 74(10 cz 2):2640-2645. PubMed ID: 34923473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease].
    Rasskazova MA; Vorobyev SV; Butova HN
    Ter Arkh; 2023 May; 95(4):316-321. PubMed ID: 38158979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Risk of Developing Non-Alcoholic Fatty Liver Disease in Adult Patients with Subclinical Hypothyroidism Compared to Euthyroid: An Evidence-based Case Report.
    Notariza KR; Wisnu W
    Acta Med Indones; 2019 Apr; 51(2):179-188. PubMed ID: 31383835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015.
    Lee J; Ha J; Jo K; Lim DJ; Lee JM; Chang SA; Kang MI; Cha BY; Kim MH
    Sci Rep; 2018 Oct; 8(1):15145. PubMed ID: 30310098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANTHROPOMETRIC CHARACTERISTICS AND PARAMETERS OF LIPID-CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION DEPENDING ON THE DEGREE OF HEPATIC STEATOSIS].
    Babak О; Bashkirova А
    Georgian Med News; 2018 Nov; (284):59-65. PubMed ID: 30618391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination].
    Zhuravleva LV; Ogneva EV
    Eksp Klin Gastroenterol; 2014; (8):21-6. PubMed ID: 25911908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.
    Patel PJ; Hayward KL; Rudra R; Horsfall LU; Hossain F; Williams S; Johnson T; Brown NN; Saad N; Clouston AD; Stuart KA; Valery PC; Irvine KM; Russell AW; Powell EE
    Medicine (Baltimore); 2017 Jun; 96(26):e6761. PubMed ID: 28658094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.
    Bril F; Kadiyala S; Portillo Sanchez P; Sunny NE; Biernacki D; Maximos M; Kalavalapalli S; Lomonaco R; Suman A; Cusi K
    J Investig Med; 2016 Jan; 64(1):63-8. PubMed ID: 26755815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.